Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
17 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/17/2947279/37216/en/Aclaris-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2a-Clinical-Trial-of-ATI-2138-an-Investigational-Oral-Covalent-ITK-JAK3-Inhibitor-for-the-Treatment-of-Moderate-to-Sever.html
10 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/10/2943489/37216/en/Aclaris-Therapeutics-to-Participate-in-the-2024-Cantor-Global-Healthcare-Conference.html
07 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/07/2925807/37216/en/Aclaris-Therapeutics-Reports-Second-Quarter-2024-Financial-Results-and-Provides-a-Corporate-Update.html
16 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/07/16/2914146/37216/en/Aclaris-Therapeutics-Announces-Sale-of-OLUMIANT-Royalties-and-Milestones-to-OMERS-Life-Sciences-for-Up-to-31-5-Million.html
06 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/06/2894539/37216/en/Aclaris-Therapeutics-to-Participate-in-the-Goldman-Sachs-45th-Annual-Global-Healthcare-Conference.html
06 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/07/2877176/37216/en/Aclaris-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Provides-a-Corporate-Update.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?